Introduction {#S0001}
============

Persistent Organic Pollutants (POPs) including polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs) and perfluorinated alkyl acids have long half-lives and bio-magnify through the food chain and are found in animals and humans. The Arctic Monitoring and Assessment Programme has been performing circumpolar monitoring of POPs since the beginning of the 1990s \[[1](#CIT0001)\]. The foetus is exposed to POPs during pregnancy and further through breastfeeding as a child. The POPs can have health impact on pregnant women and their foetus during development. Inuit dieting traditional including marine mammals have high serum concentrations of POPs being further increased upon smoking possibly due to a common pathway for metabolism via the P-450 cytochrome system \[[1](#CIT0001)\]. Moreover, maternal serum concentrations of POPs have been reported to be associated with increased risk of asthma in the offspring \[[2](#CIT0002)\], and studies showed that breastfeeding can modify offspring risk of asthma and current asthma reduced by month of breastfeeding \[[3](#CIT0003)\]. The ACCEPT birth cohort, established during 2010--2015, is a Greenlandic geographical mother-child cohort including 592 Inuit pregnant women holding data on mothers lifestyle, diet questionnaires and sampling of hair, blood and urine for POP monitoring and toxicological analyses. To investigate the effect of mothers lifestyle during pregnancy on offspring's health, a pilot follow-up study on ACCEPT children health and development at 3--5 years old was conducted using data from the Inuit mothers´ questionnaire participating in the project during 2010--2011. The questions referred to child development, their achievement of milestones, social skills, diet and health status including disease diagnosis such as asthma, allergy and eczema.

Materials and methods {#S0002}
=====================

Out of 120 questionnaires, 51 responded of which two were not Inuit and excluded. Answers were entered into EPIDATA twice and transferred to the statistic programme SPSS. Odds ratios (ORs) were calculated using logistic regression analysis to investigate the association between smoking during pregnancy and the risk of children's asthma, eczema or allergy the (defined in [Table 1](#T0001)) as well as the associations between the diseases. Effect of breastfeeding was analysed by stratifying breastfeeding into two periods, less or more than 12 months, respectively. The statistical significant level was set to p ≤ 0.10.10.1080/22423982.2019.1682421-T0001Table 1.Maternal characteristics.Maternal Characteristics: For further information about the study population: https://doi.org/10.3402/ijch.v74.29469; https://www.ncbi.nlm.nih.gov/pubmed/26011616; https://journals.sagepub.com/doi/pdf/10.1177/1403494817714188Parity:Mean 0.90, SD: 0.805, Median: 1.0, min-max: 0-2\
Parity = 0: 19 (38.8%), parity = 1: 17 (34.7%), parity \> = 2: 13 (26.5%)Smoking:*Smoking during pregnancy*: 10 out of 47 mothers were smoking during pregnancy;\
*Smoking during child age 0 -- 3/5 year of age*: 16 current smokers (of which 7 smoked during pregnancy), 19 former smokers, 12 never-smoking;\
7 quit smoking during pregnancy, but resumed smoking after giving birth.Breastfeeding:*All 49 children were breastfed*: 0-6 months (n = 9);\
6-12 months (n = 18); \>12 months (n=22)Alcohol:*Before pregnancy*: \<1 /month: n = 23, 1 /month: n = 8 (17%), 2-3 /month: n = 10, \> 1 /week: n = 6\
*During pregnancy*: \< 1 /month: n = 46, 1 /month: n = 1, 2-3 /month: n=1Sum POPs\
(sumPCB + sumOCP) µg/kg serum lipid, median*Smokers (n = 15)*: 434.35 µg/kg lipid, *former smokers* (n = 18): 383.25 ug/kg lipid; *Never-smoking* (n=12) 351.95 µg/kg lipid. Linea regression coefficient (β = -167, 95%CI: -505, 172, p = 0.326).\
https://www.ncbi.nlm.nih.gov/pubmed/12747516 **Allergy**\
(Cases defined as those with an unspecified allergy diagnosis (diagnosed by a physician) and those with symptoms of allergy but no final allergy diagnosis yet)Risk of offspring allergy by maternal smoking during pregnancyCase/non-caseOR95% CI*p*All9/38   Non smoking6/311 (ref)- Smoking3/72.210.44; 11.080.333Breastfeeding \< 12 months6/20   Non smoking3/171 (ref)- Smoking3/35.670.75; 42.58**0.092\*\***Breastfeeding \> 12 months3/18   Non smoking3/141 (ref)- Smoking0/40-0.999 **Asthma**\
(Cases defined as those with a diagnosis (diagnosed by a physician) and those with symptoms of asthma but no final diagnosis yet).Risk of offspring asthma by maternal smoking during pregnancyCase/non-caseOR95% CI*p*All18/27   Non smoking16/201 (ref)\--Smoking2/70.360.07; 1.960.236Breastfeeding \< 12 months10/15   Non smoking9/101 (ref)\--Smoking1/50.220.02; 2.280.205Breastfeeding \> 12 months8/12   Non smoking7/101 (ref)\--Smoking1/20.710.05; 9.500.799 **Eczema**\
(Cases defined as those with a diagnosis (diagnosed by a physician) and those with symptoms of eczema but no final diagnosis yet).Risk of offspring eczema by maternal smoking during pregnancyCase/non-caseOR95% CI*p*All8/39   Non smoking7/301 (ref)\--Smoking1/90.480.05; 4.400.513Breastfeeding \< 12 months5/21   Non smoking4/161 (ref)\--Smoking1/50.800.07; 8.910.856Breastfeeding \> 12 months3/18   Non smoking3/141 (ref)\--Smoking0/40\--0.999 **Asthma**\
(Cases defined as those with a diagnosis (diagnosed by a physician) and those with symptoms of asthma but no final diagnosis yet).Risk of child asthma for child with eczema^\#^Case/non-caseOR95% CI*p*All19/28   Non-eczema11/271 (ref)\--Having eczema8/119.642.19; 176.1**0.008\***Breastfeeding \< 12 months11/15   Non-eczema5/151 (ref)  Having eczema6/04.84x10^9^-0.999Breastfeeding \> 12 months8/13   Non-eczema6/121 (ref)\--Having eczema2/14.000.30; 53.470.295*Mothers smoking after birthChildren having both asthma and eczema*\
*Smokers/non-smokers: 2/5* **Allergy**\
(Cases defined as those with a diagnosis (diagnosed by a physician) and those with symptoms of allergy but no final diagnosis yet).Risk of child allergy for child with eczema^\#\#^Case/non-caseOR95% CI*p*All10/39   Non-eczema7/331 (ref)\--Having eczema3/62.360.47; 11.770.296Breastfeeding \< 12 months6/21   Non-eczema5/161 (ref)\--Having eczema1/50.640.06; 6.850.712Breastfeeding \> 12 months4/18   Non-eczema2/171 (ref)\--Having eczema2/117.001.02; 283.01**0.048\****Mothers smoking after birthChildren having both allergy and eczema*\
*Smokers/non-smokers: 0/3* **Asthma**\
(Cases defined as those with a diagnosis (diagnosed by a physician) and those with symptoms of asthma but no final diagnosis yet).Risk of child asthma for with child allergy^\#\#\#^Case/non-caseOR95% CI*p*All19/28   Non-allergy14/231 (ref)\--Having allergy5/51.640.40; 6.080.489Breastfeeding \< 12 months11/15   Non-allergy9/111 (ref)\--Having allergy2/40.610.09; 4.140.614Breastfeeding \> 12 months8/13   Non-allergy5/121 (ref)\--Having allergy3/17.200.60; 87.020.121*Mothers smoking after birthChildren having both asthma and allergy*\
*Smokers/non-smokers: 2/3*[^1]

Results {#S0003}
=======

Risk of getting allergy was higher among offspring born by mothers smoking during pregnancy and breastfed for less than 12 months ([Table 1](#T0001)). The risk of having asthma was higher for children already suffering from eczema, although the significance disappeared when stratifying for breastfeeding duration. Furthermore, we found a higher allergy risk when the offspring also had eczema and had been breastfed for more than 12 months.

Discussion {#S0004}
==========

Although we must interpret our data with cautions due to low power, we observed the following. The risk of allergy was significantly higher among children born by maternal smokers when breastfed for less than 12 months. This risk seemed attenuated upon being breastfed more than 12 months. The risk of child asthma or eczema was not significantly associated with mothers smoking during pregnancy. However, children suffering from eczema, the child had a significantly higher risk of having asthma, and higher risk of having allergy when being breastfeed for more than 12 months. The data suggest that the duration of breastfeeding might modify asthma and allergy risk in the infant, when the mother has been smoking during pregnancy. The increased risk of allergy in children suffering from eczema upon breastfeeding for more than 12 months might be because longer breastfeeding increases the child POP burden influencing allergy risk. Our study is too small to make conclusions and further study needed to elucidate the findings.
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[^1]: \*: significance level p ≤ 0.05; \*\*significance level p ≤ 0.1; ^\#^: Smoking during pregnancy (asthma) cases/non-case: 2/7. ^\#\#^: Smoking during pregnancy (eczema) cases/non-case: 1/9; ^\#\#\#^: Smoking during pregnancy (allergy): cases/non-case 3/7.
